Hemoglobin F

Hemoglobin F is the fetal form of hemoglobin, the protein in red blood cells that carries oxygen. In early life it is the dominant hemoglobin, then it usually decreases as the adult forms take over. The Hemoglobin F test measures how much of your total hemoglobin is the fetal type, typically reported as a percentage.

Clinicians use specialized methods such as high performance liquid chromatography or capillary electrophoresis to quantify Hemoglobin F. The result helps distinguish normal developmental patterns from inherited conditions that affect hemoglobin production.

Measuring Hemoglobin F helps evaluate for hemoglobin disorders such as thalassemias, hereditary persistence of fetal hemoglobin, and conditions affecting the beta globin gene. It is also used in the care of people with sickle cell disease, since some treatments aim to raise Hemoglobin F to improve red blood cell stability and reduce complications.

Your clinician may order this test if there are signs of anemia, abnormal red cell indices on a complete blood count, a family history of hemoglobinopathies, or to monitor response to therapies that modify hemoglobin. It can also provide clues about bone marrow recovery after illness or chemotherapy.

Your Hemoglobin F level is interpreted alongside your complete blood count, iron studies, and hemoglobin separation studies. A modest increase can occur with certain inherited traits, during pregnancy, or when the bone marrow is recovering after stress. Some medicines used for sickle cell disease are intended to raise Hemoglobin F, so higher values in that setting can reflect a desired treatment effect.

If your result is higher than expected and unexplained by treatment or life stage, your clinician may recommend confirmatory testing, review of family history, or genetic studies. If it is lower or unchanged when an increase was the goal, your care team may adjust therapy. Always discuss results in the context of your symptoms and overall health rather than in isolation.